Results 151 to 160 of about 686 (178)

Therapeutic approaches for Duchenne muscular dystrophy

Nature Reviews Drug Discovery, 2023
Thomas C Roberts, Kay E Davies
exaly  

Duchenne muscular dystrophy

Nature Reviews Disease Primers, 2021
Dongsheng Duan, Nathalie Goemans, Shin’ichi Takeda   +2 more
exaly  

Spinal muscular atrophy

Nature Reviews Disease Primers, 2022
Francesco Muntoni, Richard S Finkel
exaly  

Redução da fadiga muscular sob estimulação eletrica neuro-muscular

2021
openaire   +1 more source

Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial

Nature Medicine, 2022
Kevin A Strauss, Michelle A Farrar Mbbs, Kayoko Saito   +2 more
exaly  

Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial

Nature Medicine, 2022
Kevin A Strauss, Michelle A Farrar Mbbs, Francesco Muntoni   +2 more
exaly  

Base editing rescue of spinal muscular atrophy in cells and in mice

Science, 2023
Mandana Arbab, Zaneta Matuszek, Kaitlyn Kray   +2 more
exaly  

Fisiologia da fadiga muscular : Fatores Centrais e Periféricos

Anais do Simpósio Uninorte de Fisiologia e Biomecânica
William Mady Graciliano, Andréia Nunes Da Silva, Nadime Peres Rocha, Antonia Iris Rufino Guimarães, Elizangela Fernandes Da Penha, Jamilly Monteiro Gois, Jonh Wesley, Joaquim Albuquerque Viana   +7 more
openaire   +1 more source

Pharmacological strategies for muscular dystrophy

Nature Reviews Drug Discovery, 2003
Tejvir S Khurana, Kay E Davies
exaly  

ANÁLISE MATEMÁTICA DA FADIGA MUSCULAR EM INDIVÍDUOS SAUDÁVEIS DURANTE CONTRAÇÕES VOLUNTÁRIAS

Anais do V Congresso Brasileiro de Eletromiografia e Cinesiologia e X Simpósio de Engenharia Biomédica, 2018
A. F. V. Martins, F. M. Lana, F. E. Torres, C. C. Takahashi, G. M. Amaral, R. F. Kozan, H. R. Martins   +6 more
openaire   +1 more source